Aifeng Lyu
Executive DirectorDr. Aifeng Lyu is an Executive Director of Hansoh Pharmaceutical Group Company Limited since March 11, 2016. Dr. Lyu was appointed as Director and President of Jiangsu Hansoh in December 2015. Dr. Lyu is primarily responsible for overall management of the business operations and the scientific development of Hansoh Pharmaceutical Group. Dr. Lyu has management experience in R&D and product quality control systems in the pharmaceutical industry. Dr. Lyu joined Hansoh Pharmaceutical Group in July 1998 and has served in various positions, including director of product development in August 2001, and Director of research institution in March 2009. Dr. Lyu was also appointed as President of Jiangsu Hansoh and the General Manager of Shanghai Hansen in December 2015 and April 2016, respectively. Dr. Lyu has obtained numerous awards and recognitions. Dr. Lyu obtained the “State Science and Technology Progress Award (second prize) in 2013 and 2014. Dr. Lyu was recognized as a "Young Expert with Outstanding Contributions” by the People’s Government of Jiangsu Province in March 2015. He was also chosen for the “100 Million Talents Programme” by the PRC Ministry of Human Resources and Social Security in October 2017. He was further selected for the Ten Thousand Talents Programme” by the PRC Ministry of Science and Technology in May 2018. Dr. Lyu obtained Bachelor of Science degree in Chemistry and Master of Science degree in Organic Chemistry from Nanjing University, in July 1998 and June 2005, respectively. Dr. Lyu also obtained Doctorate degree in Biomedical Engineering from Southeast University in Nanjing in June 2015.
Positions
- Company NameHansoh Pharmaceutical Group Company LimitedStock Code03692PositionExecutive Director
